RE: What not to like about the NEW VAL?14 Nov 2020 20:57
Right then. First of all, if one needs to be invested here, in order to be able to voice an opinion, then I qualify.
The fact is however, that no one is required to be invested here, in order to articulate* an opinion. The reason antofelli is getting so much grief, appears to to me (essentially), due to him/her not falling under the catargory: 'blatant ramper'.
Perhaps, if criticism is merited, if might be reserved for those who - oh, I don't know, lets see... err - rely on TA for instance?
As I've mooted before, TA is of little value for news driven tiddlers on AIM. We've had two significant batches of news this week. The first relating to a 'yet to be approved' covid vaccine, the second was a VAL's 'tie-up' with Kalos.
The former shouldn't have made much difference since VAL revolves around oncology R&D, the second should have boosted the shares towards the 28p targeted by Iceman in his musings of last Sunday evening.
Yet here we are at 19.5/20p, content to concentrate our rancorous ire, at antofelli's egregious grammatical prowess.
* 'articulate' as in 'delicious irony'.